Presented by Marcos Rubio – CTO & Founder, Tucuvi

Tucuvi is a Voice AI care management platform with autonomous agents that engage patients through clinical conversations, driving outcomes and closing gaps across the care journey. A hybrid AI architecture pairs deterministic clinical models with Generative AI, ensuring clinical precision while eliminating hallucination risk.

Presented by Marisse Masis-Solano – Founder, Iriscience

Iriscience is a digital health company developing AI-powered, software-only ophthalmic diagnostics that operate on FDA-approved portable imaging devices. By focusing on accessibility, diverse datasets, and clinician-centered design, Iriscience aims to transform preventive eye care and improve early intervention at scale.

The mental health AI revolution promised wearables and smartphones detecting behavioral changes that signal shifts in mental health, social media analysis flagging suicide risk, and new chatbots promising what their predecessors couldn't deliver. Yet this revolution hasn’t arrived—pioneering companies have collapsed, chatbots have been linked to teen suicides, and the FDA still hasn't figured out how to regulate therapy delivered by AI. This panel brings together researchers who built the science, funders betting on its future, and clinicians who see patients every day, moderated by a journalist who has documented both the breakthroughs and the failures. Together, they'll confront some of the field's most pressing questions around safety, privacy, and more.

Presented by Thomas Conroy, PhD – CEO, SensVita

SensVita is redefining chronic disease monitoring with continuous, contactless cardiopulmonary sensing powered by a versatile RF platform. By transforming passively acquired data into actionable insights, SensVita supports value-based care, reduces avoidable admissions, and improves the experience for both patients and families.

Presented by Yiran Zhao, PhD – CEO, SomaBeats Health

SomaBeats Health presents CalmingBeats, a wearable, neuroscience-backed anxiety intervention designed to address the rising prevalence of chronic anxiety in today’s overstimulated, high-demand environment. Rather than relying on cognitively intensive strategies such as prompts or exercises, CalmingBeats delivers a physiology-driven intervention through a proprietary haptic neuromodulation sequence, directly engaging the autonomic nervous system.

What does it take to grow a healthcare startup from early traction to lasting impact? This panel brings together Cornell founders who have scaled AI-powered healthcare companies serving millions of patients, navigated enterprise sales cycles, and guided strategic acquisitions, alongside legal counsel who advises on responsible tech and AI governance practices, IP strategies, and data rights issues that can make or break a deal.

This panel brings together both academic faculty founders and institution leaders who are actively advancing the translation of academic research into real-world impact. From launching startups to building institutional pathways that support commercialization, these leaders are reshaping how academics engage with industry and society. Panelists will share perspectives on moving ideas from lab to market, fostering entrepreneurial culture within academic institutions, and balancing scholarly excellence with innovation and impact. The discussion will highlight practical lessons for academic researchers and leaders seeking to accelerate meaningful translation without compromising academic mission.

Presented by Malwina Lewicka, PhD – Founder & CEO, Sanexus

Sanexus’s Asta, an agentic AI adjunct for supportive cancer care, delivers guideline-concordant, adaptive, real-time guidance across the care journey. For cancer centers, Asta provides scalable supportive care infrastructure. For patients, it’s one seamless conversation accessible via an app.

Presented by Royi Rozen – Founder, MedComm

MedComm helps hospitals close the gap between discharge and follow-up through a protocol-driven AI that supports patients over SMS and voice, detects deterioration early, and escalates to the right care teams in time to intervene before problems become costly returns to the hospital.